Methylprednisolone Acetate I · #20 of 35 active shortages by FDA posting duration
Brand: METHYLPREDNISOLONE ACETATE
FDA lists Methylprednisolone Acetate I as Active Shortage (Eugia US LLC).
Availability on file: Unavailable
Methylprednisolone Acetate Injection: Active Shortage
Unavailable 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Methylprednisolone Acetate Injection
- Manufacturer
- Eugia US LLC
- Dosage Form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01)
- Package NDC
- 55150-314-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Dec 15, 2021
- Last Updated
- Mar 18, 2026
- Therapeutic Category
- Rheumatology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
On backorder. Recovery: TBD. Check wholesalers for inventory
Full Drug Profile
methylprednisolone
Side effects, interactions, warnings & more
Nearby, Other Methylprednisolone Shortage Records
Methylprednisolone Acetate Injection
Eugia US LLC
Injection
Methylprednisolone Acetate Injection
Par Health, USA LLC
Injection
Methylprednisolone Acetate Injection
Sagent Pharmaceuticals
Injection
Methylprednisolone Acetate Injection
Sagent Pharmaceuticals
Injection
Methylprednisolone Acetate Injection
Sagent Pharmaceuticals
Injection
Methylprednisolone Acetate Injection
Pfizer Inc.
Injection
FDA reason on file: On backorder. General shortage guidance lives on the tracker hub.